Announcement on Top 10 Shareholders and Top 10 Shareholders of Unrestricted Shares Concerning Share Repurchase
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Top 10 Shareholders and Top 10 Shareholders of Unrestricted Shares Concerning Share Repurchase
Filed with SSE · Stock code 688578 ·
6ix is reading this filing.
View original source (Shanghai Stock Exchange)Shanghai Allist Pharmaceuticals Co. Ltd. on 6ix
Story so far
- (688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Initial Repurchase of Shares through Call Auction
- (688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Share Repurchase Plan through Call Auction
- (688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Resolutions of the 5th Meeting of the 3rd Board of Directors
Earlier from Shanghai Allist Pharmaceuticals
- (688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Initial Repurchase of Shares through Call Auction
- (688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Share Repurchase Plan through Call Auction
- (688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Resolutions of the 5th Meeting of the 3rd Board of Directors
- (688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Proposal by the Actual Controller, Chairman and General Manager to Repurchase Company Shares
- (688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Progress of the Pivotal Clinical Trial of Furmonertinib for First-line Treatment of NSCLC with EGFR Exon 20 Insertion Mutations
Follow Shanghai Allist Pharmaceuticals into a list and get an email when it puts out news.
Follow Shanghai Allist Pharmaceuticals